R. Woods
Director/Board Member chez X4 PHARMACEUTICALS, INC.
Fortune : 1 M $ au 29/02/2024
Profil
Actuellement, R. Keith Woods occupe le poste de directeur de l'exploitation d'argenx SE. Dans sa carrière antérieure, il a occupé le poste de SVP-North American Operations chez Alexion Pharmaceuticals, Inc. et de vice-président et directeur général chez Alexion Pharma UK Ltd. (une filiale d'Alexion Pharmaceuticals, Inc.). Il est titulaire d'un diplôme de premier cycle de la Florida State University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
ARGEN-X SE
0,01% | 20/02/2024 | 3 307 ( 0,01% ) | 1 M $ | 29/02/2024 |
X4 PHARMACEUTICALS, INC.
0,05% | 16/10/2023 | 90 000 ( 0,05% ) | 87 390 $ | 29/02/2024 |
Postes actifs de R. Woods
Sociétés | Poste | Début |
---|---|---|
X4 PHARMACEUTICALS, INC. | Director/Board Member | 16/10/2023 |
TSCAN THERAPEUTICS, INC. | Director/Board Member | 06/12/2023 |
ROCKET PHARMACEUTICALS, INC. | Director/Board Member | 12/12/2023 |
Anciens postes connus de R. Woods
Sociétés | Poste | Fin |
---|---|---|
ARGENX SE | Chief Operating Officer | 13/03/2023 |
Alexion Pharma UK Ltd.
Alexion Pharma UK Ltd. Medical DistributorsDistribution Services Part of AstraZeneca PLC, Alexion Pharma UK Ltd. is a pharmaceutical wholesaler founded in 2006. The private company is based in Middlesex, UK. | Corporate Officer/Principal | - |
ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de R. Woods
Florida State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 4 |
---|---|
ARGENX SE | Health Technology |
ROCKET PHARMACEUTICALS, INC. | Health Technology |
TSCAN THERAPEUTICS, INC. | Health Technology |
X4 PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Alexion Pharma UK Ltd.
Alexion Pharma UK Ltd. Medical DistributorsDistribution Services Part of AstraZeneca PLC, Alexion Pharma UK Ltd. is a pharmaceutical wholesaler founded in 2006. The private company is based in Middlesex, UK. | Distribution Services |